Authors' reply

The Lancet

Volumn 381, Issue 9862, 2013, Pages 200-201

  Depani, Sarita ^a   Mallewa, MacPherson ^a   Kennedy, Neil ^a   Molyneux, Elizabeth ^a   Warrell, Mary ^b  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

CLINICAL PRACTICE; COST CONTROL; DOG BITE; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; IMMUNOGENICITY; LETTER; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; RABIES; STANDARD; VACCINATION; WORLD HEALTH ORGANIZATION; NOTE;

HUMANS; RABIES;

EID: 84872524557     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/s0140-6736(13)60083-5     Document Type: Letter

References (5)

1. Gongal G, Wright AE. Human rabies in the WHO Southeast Asia Region: forward steps for elimination. Adv Prev Med 2011; 2011; 383870.
2. Warrell M J. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure. Travel Med Infect Dis 2012; 10: 1-15.
3. Hampson K, Cleaveland S, Briggs D. Comparison of PEP vaccination regimens including the proposed 4-site ID regimen reduced to a schedule with 3 clinic visits. http://www.plosntds.org/attachments/pntd.0000982-Response-to- Warrell16Mar11. pdf (accessed Jan 3, 2013).
4. Cleaveland S, Kaare M, Tiringa P, et al. A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries. Vaccine 2003; 21: 1965-73.
5. Lembo T, Hampson K, Kaare MT, et al. The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis 2010; 4: e626.